Literature DB >> 2440379

Different patterns of inhibition of avian myeloblastosis virus reverse transcriptase activity by 3'-azido-3'-deoxythymidine 5'-triphosphate and its threo isomer.

B Eriksson, L Vrang, H Bazin, J Chattopadhyaya, B Oberg.   

Abstract

The two isomers 3'-azido-3'-deoxythymidine 5'-triphosphate (erythro-AZT-TP) and 1-(3'-azido-2',3'-dideoxy-beta-D-xylofuranosyl)thymine 5'-triphosphate (threo-AZT-TP) were studied as inhibitors of the reverse transcriptase activity of avian myelobastosis virus. Kinetic analysis of the (rA)n X (dT)12-18 (a standard template primer complex of polyriboadenylate and oligodeoxythymidylate of indicated length)-directed reaction revealed that erythro-AZT-TP was a competitive inhibitor with respect to dTTP, whereas threo-AZT-TP was a noncompetitive inhibitor. The apparent Ki values, as calculated from Dixon plots, were 0.48 and 5.5 microM, respectively, compared with a Km value for dTTP of about 70 microM. These results indicate that erythro-AZT-TP had an approximately 150-times-higher affinity to the enzyme than dTTP had and that the avian myeloblastosis virus reverse transcriptase had different binding sites for the two isomers.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2440379      PMCID: PMC174784          DOI: 10.1128/AAC.31.4.600

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  10 in total

1.  In search of specific inhibitors of retrovirus replication.

Authors:  E De Clercq; J Balzarini
Journal:  Antiviral Res       Date:  1985       Impact factor: 5.970

2.  Antiviral chemotherapy against HTLV-III/LAV infections.

Authors:  B Oberg
Journal:  J Antimicrob Chemother       Date:  1986-05       Impact factor: 5.790

3.  Coexistence of beta1 and beta2 adrenoceptors in mammalian lung: evidence from direct binding studies.

Authors:  E L Rugg; D B Barnett; S R Nahorski
Journal:  Mol Pharmacol       Date:  1978-11       Impact factor: 4.436

4.  Rose Bengal mediated inhibition of DNA polymerases: mechanism of inhibition of avian myeloblastosis virus reverse transcriptase under nonoxidative conditions.

Authors:  S K Srivastava; M J Modak
Journal:  Biochemistry       Date:  1982-09-14       Impact factor: 3.162

Review 5.  Agents which inhibit reverse transcriptases.

Authors:  R G Smith; R C Gallo
Journal:  Life Sci       Date:  1974-11-15       Impact factor: 5.037

6.  Phosphonoformate inhibits reverse transcriptase.

Authors:  B Sundquist; B Oberg
Journal:  J Gen Virol       Date:  1979-11       Impact factor: 3.891

7.  Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.

Authors:  H Mitsuya; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

8.  3'-Azido-3'-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro.

Authors:  H Mitsuya; K J Weinhold; P A Furman; M H St Clair; S N Lehrman; R C Gallo; D Bolognesi; D W Barry; S Broder
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

9.  Inhibition of reverse transcriptase activity of avian myeloblastosis virus by pyrophosphate analogues.

Authors:  B Eriksson; G Stening; B Oberg
Journal:  Antiviral Res       Date:  1982-05       Impact factor: 5.970

10.  Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

Authors:  P A Furman; J A Fyfe; M H St Clair; K Weinhold; J L Rideout; G A Freeman; S N Lehrman; D P Bolognesi; S Broder; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

  10 in total
  6 in total

1.  3'-Azido-3'-deoxythymidine triphosphate as an inhibitor and substrate of purified human immunodeficiency virus reverse transcriptase.

Authors:  M H St Clair; C A Richards; T Spector; K J Weinhold; W H Miller; A J Langlois; P A Furman
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191

2.  Comparison of inhibitory activities of various antiretroviral agents against particle-derived and recombinant human immunodeficiency virus type 1 reverse transcriptases.

Authors:  R F Schinazi; B F Eriksson; S H Hughes
Journal:  Antimicrob Agents Chemother       Date:  1989-01       Impact factor: 5.191

3.  Combinations of 3'-azido-3'-deoxythymidine (zidovudine) and phosphonoformate (foscarnet) against human immunodeficiency virus type 1 and cytomegalovirus replication in vitro.

Authors:  B F Eriksson; R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

Review 4.  Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  H D Langtry; D M Campoli-Richards
Journal:  Drugs       Date:  1989-04       Impact factor: 9.546

5.  Phosphorylation of 3'-azido-2',3'-dideoxyuridine and preferential inhibition of human and simian immunodeficiency virus reverse transcriptases by its 5'-triphosphate.

Authors:  B F Eriksson; C K Chu; R F Schinazi
Journal:  Antimicrob Agents Chemother       Date:  1989-10       Impact factor: 5.191

6.  Inhibition of human immunodeficiency virus (HIV-1/HTLV-IIIBa-L) replication in fresh and cultured human peripheral blood monocytes/macrophages by azidothymidine and related 2',3'-dideoxynucleosides.

Authors:  C F Perno; R Yarchoan; D A Cooney; N R Hartman; S Gartner; M Popovic; Z Hao; T L Gerrard; Y A Wilson; D G Johns
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.